So they will approach Medasfe about NTcell June 2019, presumably with 2 year data from the complete trial. That will potentially give time for publication and maybe peer review. 7-8months more.
The data looks promising, but nothing is guaranteed.
Meantime they have a few other irons in the fire.
So they will approach Medasfe about NTcell June 2019, presumably...
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $1.942K | 277.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 8049466 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 303460 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |